Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Filed Mar 11, 2020 · 10-K · 71 days after period end · 0001140361-20-005499
| Metric | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|
| Revenue | $16.42M | $16.82M | $12.19M |
| Net Income | -$12.64M | -$13.94M | -$10.04M |
| EPS Diluted | -$0.48 | -$0.56 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 11, 2020 · 71 d after period end
